ORPHA:100997
X-linked spastic paraplegia type 16
Also known as: SPG16
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
42
36.5th percentile
Trials
0
Interventional, condition-specific
Researchers
309
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A complex, , spastic paraplegia characterized by delayed motor development, spasticity, and inability to walk, later progressing to quadriplegia, motor aphasia, bowel and bladder dysfunction. Patients also present with vision problems and mild . The disease affects only males.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010287
- MeSH:C536643
- OMIM:300266
- UMLS:C1846046
Additional Mondo synonyms (2)
hereditary spastic paraplegia type 16 · spastic paraplegia 16, X-linked, complicated, X-linked recessive
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
42 matched papers (21 in last 10 years) Source
- Phenotype characterisedPresent
30 HPO annotations (e.g. Mild intellectual disability; Motor delay; Abnormal hallux morphology) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 104 for broader category paraplegia
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
30
Associated phenotypes · MONDO:0010287
- Mild intellectual disability
- Motor delay
- Abnormal hallux morphology
- Functional abnormality of the bladder
- Functional abnormality of the gastrointestinal tract
Showing 5 of 30 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
42
42 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
42 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
21 in the last 10 years · high confidence · 36.5th percentile (publications denominator)
Phrase hits: 42 · MeSH hits: 0
Who's working on it?
309
Distinct author names in 42 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Barrio E3 papers · 2012Papers in Europe PMC
- 02Johnston GD3 papers · 2001Papers in Europe PMC
- 03Stevanin G3 papers · 2021
Université Pierre and Marie Curie - Paris VI, Unité Mixte de Recherche S975, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France; Institut National de la Santé et de la Recherche Médicale, Unité 975, 75013 Paris, France; Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7225, 75013 Paris, France; Laboratoire de Neurogénétique, Ecole Pratique des Hautes Etudes, Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France; Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France. Electronic address: giovanni.stevanin@upmc.fr.
Papers in Europe PMC - 04Belloch C2 papers · 2012
Instituto de Agroquímica y Tecnología de los Alimentos, IATA-CSIC, P.O. Box 73, E-46100 Burjassot, Spain.
Papers in Europe PMC - 05Hanratty CG2 papers · 2001
Department of Therapeutics and Pharmacology, Queen's University of Belfast, Whitla Medical Building, 97 Lisburn Rd, Belfast BT9 7BL, UK. c.hanratty@net.ntl.com
Papers in Europe PMC - 06Lopes CA2 papers · 2012Papers in Europe PMC
- 07Maguire S2 papers · 1999Papers in Europe PMC
- 08McAuley D2 papers · 1999
Department of Therapeutics and Pharmacology, Queen's University of Belfast, Northern Ireland.
Papers in Europe PMC - 09McAuley DF2 papers · 2001Papers in Europe PMC
- 10McGrath LT2 papers · 2001Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 104 trials are registered for paraplegia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
104 interventional trials matched paraplegia, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: paraplegia
104
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06777576·RECRUITING·Self-balancing Personal Exoskeleton for SCI
Conditions: Spinal Cord Injuries (SCI) · Paraplegia and Tetraplegia·Matched via name phrase
- NCT07803276·RECRUITING·Comparison Between Palpatory and Ultrasound-guided Methods for Botulinum Toxin Administration in Spastic Paraplegia
Conditions: Spastic Paraplegia·Matched via name phrase
- NCT06829212·RECRUITING·Research on Wireless Brain Implant System for General Control of External Devices
Conditions: Complete or Incomplete Paraplegia/quadriplegia · Spinal Cord Injury · Brainstem Stroke · Amyotrophic Lateral Sclerosis·Matched via name phrase
- NCT06814015·RECRUITING·Self-balancing Personal Exoskeleton for SCI (Site 2)
Conditions: Spinal Cord Injuries (SCI) · Paraplegia and Tetraplegia·Matched via name phrase
- NCT06272279·RECRUITING·Neuromodulation With Spinal Stimulation Methods
Conditions: Spinal Cord Injuries · Spinal Cord Injury at C5-C7 Level · Paraplegia, Spinal · Paraplegia, Incomplete·Matched via name phrase
- NCT06742697·RECRUITING·Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Conditions: Hereditary Spastic Paraplegia·Matched via name phrase
- NCT07583576·NOT YET RECRUITING·Effects of Functional Electrical Stimulation on Spasticity, Quadriceps Muscle Strength and Functional Mobility in Individuals With Paraplegia
Conditions: Spinal Cord Injury · Paraplegia · Spasticity · Neurorehabilitation·Matched via name phrase
- NCT07625332·RECRUITING·Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Conditions: Spinal Cord Injury · Traumatic Spinal Cord Injury · Paraplegia and Tetraplegia · Metabolic Syndrome·Matched via name phrase
- NCT06478238·RECRUITING·Calcium Folinate Treatment of Spastic Paraplegia 56
Conditions: Hereditary Spastic Paraplegia·Matched via name phrase
- NCT01474148·RECRUITING·A Neuroprosthesis for Seated Posture and Balance
Conditions: Spinal Cord Injury · Paralysis · Tetraplegia · Paraplegia·Matched via name phrase
- NCT06948019·NOT YET RECRUITING·Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)
Conditions: HSP · Hereditary Spastic Paraplegia · Hereditary Spastic Paraparesis · Hereditary Spastic Paraplegia Type 50·Matched via name phrase
- NCT06261424·RECRUITING·Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
Conditions: Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay · Spastic Paraplegia 7·Matched via name phrase
- NCT07417943·RECRUITING·Neuromodulation to Enhance Motor Function in HSP
Conditions: Hereditary Spastic Paraplegia·Matched via name phrase
- NCT07732868·ENROLLING BY INVITATION·Effects of a Virtual Reality-based Brain-Machine Interface Protocol in Spinal Cord Injury
Conditions: Spinal Cord Injury · Able Bodied · Traumatic Spinal Cord Injuries · Paraplegia, Spinal·Matched via name phrase
- NCT07536386·RECRUITING·Self-balancing Personal Exoskeleton for SCI (WIP)
Conditions: Spinal Cord Injuries · Paraplegia and Tetraplegia·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for X-linked spastic paraplegia type 16 — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"X-linked spastic paraplegia type 16" OR "SPG16" OR "hereditary spastic paraplegia type 16" OR "spastic paraplegia 16, X-linked, complicated, X-linked recessive"
MeSH descriptor terms unioned into the query: Spastic paraplegia 16, X-linked
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"X-linked spastic paraplegia type 16" OR "SPG16" OR "hereditary spastic paraplegia type 16" OR "spastic paraplegia 16, X-linked, complicated, X-linked recessive" OR "Spastic paraplegia 16, X-linked"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"paraplegia"
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T07:10:12.320Z
